| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261663.1 |
AKT inhibitor VIII |
Brain lower grade glioma |
0.001187437 |
Resistant |
| ENSG00000261663.1 |
AKT inhibitor VIII |
Stomach adenocarcinoma |
0.021917004 |
Sensitive |
| ENSG00000261663.1 |
AKT inhibitor VIII |
Thyroid carcinoma |
0.006566927 |
Sensitive |
